Biotech Hubs: A Tale of Two Cities
Life science investors differ widely across biotech hubs in Europe. At Labiotech’s recent Refresh event,…
Life science investors differ widely across biotech hubs in Europe. At Labiotech’s recent Refresh event,…
Having to let go of your flagship product after years of development is not easy.…
Many biotech founders and executives look to VC investors for advice and inspiration, but the…
Sometimes things don’t go your way in the biotech industry. The CEO of Valneva, Thomas…
Genfit is poised to become the first company to get a treatment for NASH to…
After working for 12 years at Merck, Catherine Pickering decided to take a risk and…
A whole new therapeutic area is taking medical research by storm. In Cambridge, UK, the…
Vaccines are humanity’s biggest achievement against infectious diseases. But could they defeat HIV, a particularly…
The biotech sector is rapidly gaining momentum in Spain. At Labiotech Refresh in Barcelona, Raúl…
Olga Dubey founded the Swiss startup Agrosustain with the intention to bring forth a natural…
Celyad is one of many companies in the immuno-oncology field seeking to take the lead…
Andreas Wallnöfer spent over 20 years working on drug development at Roche before moving to…